Early vs. delayed invasive strategy in patients with acute coronary syndromes without ST-segment elevation: a
E P Navarese1, S De Servi, C Michael Gibson
1Institute of Cardiology, Catholic University of the Sacred Heart, Rome. eliano.navarese@alice.it
Insights
For non-ST-segment elevation acute coronary syndromes (NSTE-ACS), an early invasive strategy does not significantly improve survival or reduce myocardial infarction (MI) rates compared to a delayed approach. This meta-analysis found no significant benefit for early percutaneous coronary intervention in NSTE-ACS patients.
Area of Science:
- Cardiology
- Interventional Cardiology
- Clinical Trials
Background:
- Early percutaneous coronary intervention (PCI) is standard for acute coronary syndromes.
- Conflicting data exist regarding the optimal timing of PCI in non-ST-segment elevation acute coronary syndromes (NSTE-ACS).
- Determining the ideal invasive strategy is crucial for patient outcomes.
Purpose of the Study:
- To conduct a meta-analysis of randomized controlled trials (RCTs).
- To compare early versus delayed invasive strategies for NSTE-ACS patients.
- To evaluate the impact on mortality, myocardial infarction (MI), revascularization, and bleeding complications.
Main Methods:
- Searched Medline/CENTRAL and the Web for relevant RCTs.
- Included 5 RCTs with a total of 4155 patients.
- Utilized fixed or random effects models, including Bayesian meta-analysis for sensitivity analysis.
Main Results:
- An early invasive approach did not significantly reduce all-cause mortality (OR 0.81, P=0.17).
- Rates of myocardial infarction (MI) (OR 1.18, P=0.55) and revascularizations (OR 0.97, P=0.82) were not significantly improved.
- A non-significant trend towards fewer major bleeding complications was observed with the early strategy (OR 0.76, P=0.08).
Conclusions:
- A routine early invasive strategy does not significantly improve survival in NSTE-ACS patients compared to a delayed approach.
- Early PCI did not lead to significant reductions in MI or revascularization rates.
- The optimal timing for invasive strategies in NSTE-ACS requires further investigation.
Abstract:
Although early percutaneous coronary intervention has been demonstrated to reduce the risk of mortality in patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS), there are emerging conflicting data as to whether the catheterization needs to be done very early or whether it could be delayed while the patient receives medical therapy. The aim of the current study was to perform a meta-analysis of randomized controlled trials (RCTs) comparing early vs. delayed invasive strategies for NSTE-ACS patients. Medline/CENTRAL and the Web were searched for RCTs comparing early vs. delayed invasive strategies for NSTE-ACS patients. The primary endpoint was all cause mortality, whereas myocardial infarction (MI), coronary revascularizations and 30-day major bleeding complications were secondary end points. Fixed or random effects models were used based on statistical heterogeneity. As a sensitivity analysis, Bayesian random effects meta-analysis was performed in addition to the classical random effects meta-analysis. A total of 5 RCTs were finally included, enrolling 4155 patients. As compared with a delayed strategy, an early invasive approach did not significantly reduce the rates of death [odds ratio (OR) 95% confidence interval (95% CI) = 0.81 (95% CI 0.60-1.09), P = 0.17], MI [OR = 1.18 (95% CI 0.68-2.05), P = 0.55] or revascularizations [OR = 0.97 (0.77-1.24), P = 0.82]. There was a not significant trend toward fewer major bleeding complications for the early invasive approach [OR (95% CI) = 0.76 (0.55-1.04), P = 0.08]. The present meta-analysis shows that for NSTE-ACS patients a routine early invasive strategy does not significantly improve survival nor reduce MI and revascularization rates as compared with a delayed approach.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Angina IV: Management
Acute Coronary Syndrome V: Nursing Management

